Nasdaq Huma News Today

Shares of Humacyte, Inc. (NASDAQ:HUMA – Get Free Report) saw strong trading volume on Wednesday after an insider bought additional shares in the company. 891,494 shares traded hands during trading, a decline of 25% from the previous session’s volume of 1,189,422 shares.The stock last traded at $6.65 and had previously closed at $6.42. Specifically, Director […]

Powell Investment Advisors LLC raised its stake in shares of Humacyte, Inc. (NASDAQ:HUMA – Free Report) by 75.0% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 21,000 shares of the company’s stock after purchasing an additional 9,000 shares during the period. Powell Investment […]

Piper Sandler reiterated their neutral rating on shares of Humacyte (NASDAQ:HUMA – Free Report) in a research note issued to investors on Tuesday morning, Benzinga reports. The brokerage currently has a $4.00 price objective on the stock. Several other equities research analysts also recently commented on HUMA. HC Wainwright started coverage on shares of Humacyte […]

Piper Sandler reaffirmed their neutral rating on shares of Humacyte (NASDAQ:HUMA – Free Report) in a report published on Tuesday morning, Benzinga reports. The brokerage currently has a $4.00 target price on the stock. HUMA has been the topic of several other reports. HC Wainwright assumed coverage on shares of Humacyte in a research report […]

Benchmark reiterated their buy rating on shares of Humacyte (NASDAQ:HUMA – Free Report) in a report published on Monday, Benzinga reports. They currently have a $15.00 price target on the stock. Separately, HC Wainwright assumed coverage on Humacyte in a report on Monday, December 11th. They issued a buy rating and a $6.00 target price […]

Humacyte (NASDAQ:HUMA – Get Free Report) issued its quarterly earnings data on Friday. The company reported ($0.24) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.25) by $0.01, Yahoo Finance reports. During the same quarter last year, the company posted ($0.21) earnings per share. Humacyte Stock Down 8.1 % Shares of NASDAQ […]

Humacyte (NASDAQ:HUMA – Get Free Report) released its quarterly earnings results on Friday. The company reported ($0.24) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.25) by $0.01, Yahoo Finance reports. During the same period last year, the firm posted ($0.21) earnings per share. Humacyte Price Performance Shares of Humacyte stock opened […]

Humacyte (NASDAQ:HUMA – Get Free Report) released its quarterly earnings data on Friday. The company reported ($0.24) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.25) by $0.01, Yahoo Finance reports. During the same period in the previous year, the business posted ($0.21) EPS. Humacyte Trading Down 8.1 % Shares of HUMA […]

DURHAM, N.C., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally...

Hamilton Lane Advisors LLC trimmed its holdings in shares of Humacyte, Inc. (NASDAQ:HUMA – Free Report) by 58.5% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 21,893 shares of the company’s stock after selling 30,800 shares during the period. Humacyte […]